Overview

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

Status:
Not yet recruiting
Trial end date:
2028-03-31
Target enrollment:
Participant gender:
Summary
This study is being done to answer the following question: What are the effects of new treatments on non-small cell lung cancer before surgery?
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborator:
Novartis